You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dual antiplatelet therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)

Not yet recruiting
  • Intracranial Aneurysm
  • Stent Complication
  • Ticagrelor monotherapy
  • Dual Antiplatelet Therapy
  • (no location specified)
Aug 23, 2023

Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual

Recruiting
  • Coronary Artery Disease
  • +6 more
  • De-escalated Dual Antiplatelet Therapy
  • Dual Antiplatelet Therapy
  • Beijing, China
    Fuwai Hospital
Dec 13, 2022

Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

Not yet recruiting
  • Elevated Lipoprotein(a) Level
  • +3 more
  • 24 Months DAPT
  • 12 Months DAPT
  • Beijing, Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023

Acute Coronary Syndrome Trial (rivaroxaban)

Not yet recruiting
  • Acute Coronary Syndrome
  • (no location specified)
Feb 20, 2023

Coronary Artery Disease Trial (Angiolite: Sirolimus-eluting stent, Xience: Sirolimus-eluting stent, 1-month DAPT)

Not yet recruiting
  • Coronary Artery Disease
  • Angiolite: Sirolimus-eluting stent
  • +3 more
  • (no location specified)
Jul 11, 2023

Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided

Not yet recruiting
  • Percutaneous Coronary Intervention
  • +2 more
  • Algorithm-guided DAPT duration
  • Standard-of-care DAPT duration
  • Bern, Switzerland
    Bern University Hospital
Feb 16, 2023

Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid

Recruiting
  • Acute Coronary Syndrome
  • Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
  • Monotherapy: Ticagrelor alone OR Prasugrel alone
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Mar 2, 2023

Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)

Recruiting
  • Acute Coronary Syndrome
  • No aspirin
  • 1-month DAPT
  • Kyoto, Japan
    Kyoto University Graduate School of Medicine
Nov 16, 2022

Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual

Recruiting
  • Atrial Fibrillation
  • short postimplantation dual antiplatelet therapy
  • +3 more
  • Warsaw, Mazowieckie, Poland
    National Institute of Cardiology
Dec 14, 2022

Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)

Recruiting
  • Acute Coronary Syndrome
  • +2 more
  • Genoss DES™ stent
  • Wonju, Gangwon State, Korea, Republic of
    Wonju Severance Christian Hospital
Oct 4, 2023

Coronary Artery Disease Trial in Amsterdam

Not yet recruiting
  • Coronary Artery Disease
    • Amsterdam, Noord-Holland, Netherlands
    • +1 more
    Sep 26, 2022

    Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)

    Recruiting
    • Coronary Artery Disease
    • +2 more
    • Genoss DES™ stent
    • Wŏnju, Gangwon State, Korea, Republic of
      Wonju Severance Christian Hospital
    Oct 4, 2023

    Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx

    Recruiting
    • Ischemic Heart Disease
    • Clopidogrel monotherapy
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Oct 13, 2022

    Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic

    Recruiting
    • Aortic Stenosis
    • +4 more
    • Aspirin group
    • Non-antithrombotic group
    • Shinjuku, Tokyo, Japan
      Keio University Hospital
    Aug 17, 2023

    Tracheotomy With and Without Dual Antiplatelet Therapy

    Recruiting
    • Tracheostomy Hemorrhage
    • Tracheotomy
    • Nidda, Germany
      Neurologische Klinik Bad Salzhausen
    Oct 29, 2022

    Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual

    Recruiting
    • Atrial Fibrillation
    • short postimplantation dual antiplatelet therapy
    • +3 more
    • Warsaw, Mazowieckie, Poland
      National Institute of Cardiology
    Jun 30, 2022

    Acute Stroke, Dual Antiplatelet Therapy, Statin Trial in Chiayi City (Clopidogrel, Aspirin, Atorvastatin)

    Recruiting
    • Acute Stroke
    • +2 more
    • Chiayi City, Taiwan
      Yenchu Huang
    Jul 21, 2022

    Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor

    Not yet recruiting
    • Dual Antiplatelet Therapy
    • +2 more
    • P2Y12 inhibitor de-escalation
    • Messina, Italy
    • +1 more
    Jun 12, 2023

    Coronary Artery Disease Trial in Kyoto (1-month DAPT, 12-month DAPT)

    Active, not recruiting
    • Coronary Artery Disease
    • 1-month DAPT
    • 12-month DAPT
    • Kyoto, Japan
      Division of Cardiology, Kyoto University Hospital
    Jan 10, 2022

    Bleeding and Ischemic Risk

    Completed
    • Coronary Artery Disease
    • Percutaneous Coronary Intervention
    • Percutaneous coronary intervention
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 13, 2023

    Aneurysm Cerebral (Unruptured) Trial in New York (Endovascular Neurosurgery)

    Recruiting
    • Aneurysm Cerebral (Unruptured)
    • Endovascular Neurosurgery
    • New York, New York
      Montefiore Medical Center Department of Neurosurgery
    Dec 13, 2021

    Percutaneous Intervention Trial in Shatin (Orsiro Mission, Resolute Onyx)

    Recruiting
    • Percutaneous Intervention
    • Orsiro Mission
    • Resolute Onyx
    • Shatin, Hong Kong
      The Chinese University of Hong Kong
    Sep 19, 2022

    High Ischemic Risk Trial in Seoul (Ticagrelor-based dual-antiplatelet therapy, Clopidogrel-based dual-antiplatelet therapy)

    Not yet recruiting
    • High Ischemic Risk
    • Ticagrelor-based dual-antiplatelet therapy
    • Clopidogrel-based dual-antiplatelet therapy
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Aug 3, 2021

    Coronary Artery Disease Trial in Rome (Ticagrelor, acetylsalicylic acid)

    Recruiting
    • Coronary Artery Disease
    • Rome, Italy
      Università Campus Bio-Medico di Roma
    Jul 19, 2022

    Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul

    Completed
    • Coronary Artery Disease
    • +2 more
      • Seoul, Korea, Republic of
        Young-Hyo Lim
      Feb 24, 2023